Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyFri, 24 May 2024 18:48:48 +0200Tue, 14 May 2024 15:33:00 +0200Aspaveli : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-5553-en.pdfAspaveli : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-5553-en.pdfTue, 14 May 2024 15:33:00 +0200Human medicineHuman medicines European public assessment report (EPAR): Aspaveli, pegcetacoplan, Date of authorisation: 13/12/2021, Revision: 5, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/aspaveliHuman medicines European public assessment report (EPAR): Aspaveli, pegcetacoplan, Date of authorisation: 13/12/2021, Revision: 5, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/aspaveliTue, 14 May 2024 11:40:00 +0200Human medicine